Publication Review. Notwithstanding anything to the contrary in this Agreement, except as required by Applicable Law, from and after the Effective Date, the Developing Party shall have the sole right to publish or present the results of any work relating to the Development of Licensed Products or Licensed Compounds in the Field for which such Developing Party is responsible under this Agreement (the Party entitled to publish pursuant to this Section being hereafter referred to as the “Publishing Party”). The Publishing Party shall publish or present such results (i) in a manner consistent with the publication strategy developed by either the Joint Development Committee or the Joint Commercialization Committee and (ii) after providing the other Party with the right to review such publications or presentations to ensure the other Party’s Confidential Information is not included without the other Party’s consent and to ensure intellectual property protection. In that respect, the Publishing Party shall provide to the other Party for review any (a) abstracts, posters and slide presentations prior to any scientific meetings, and such other Party shall have at least [* * *] to provide feedback to such other Party, and (b) primary and final manuscripts and review articles prior to journal submission, and such other Party shall have at least [* * *] to provide feedback. The Party that is not the Publishing Party (i) may require that its Confidential Information that may be disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation; (ii) may require that the Publishing Party delay publication for a sufficiently long period not to exceed [* * *] in order to permit the timely preparation and filing of a patent application; and (iii) may request changes the non-Publishing Party reasonably believes are necessary to preserve any Patent Rights or Know-How belonging (whether through ownership or license, including under this Agreement) in whole or in part to the non-publishing Party or are necessary to avoid negatively impacting the Development or Commercialization of a Licensed Compound or Licensed Product, which changes, in either case, the Publishing Party will consider in good faith. Notwithstanding anything to the contrary in this Agreement, for the purpose of publication in accordance with this Section 9.2, Know-How shall not include data generated in the course of Clinical Trials conducted by the Publishing Party (as Developing Part...
Publication Review. Except as required by law, from and after the Effective Date, and subject to Section 3.2.1, Genocea shall have the sole right to publish or present the results of any work relating to the Licensed Products in the Field.
Publication Review. The Parties agree that publication of the results may be one of the goals of this Agreement, to stimulate further research in the public or private sector. In order to protect the rights of the Parties, including to avoid prejudice to the holders of Intellectual Property and Business Confidential Information, each Party shall transmit to the other for its review any material containing such results and intended for publication, or other disclosure, at least sixty (60) working days before such material is submitted to any editor, publisher, referee or meeting organiser, or is otherwise disclosed. In the absence of an objection by the other Party within that sixty-day period the publication or other disclosure may proceed. If either Party raises an objection to the public release of publications arising from this Agreement, public release will not occur unless and until there is agreement between the Parties as to the conditions for public release. It is the responsibility of each Party to coordinate with its sponsored Participants who work under a Project Arrangement to determine whether all potential Intellectual Property or Business Confidential Information interests have been properly considered.
Publication Review. All publications (abstracts and manuscripts) resulting from the use of the SAMPLES must be forwarded to the IVRN SC within one week of submission.
Publication Review. The Parties agree that publication of the results may be one of the goals of this Agreement, to stimulate further research in the public or private sector. In order to protect the rights of the Parties, including to avoid prejudice to the holders of Intellectual Property and Business Confidential Information, each Party shall transmit to the other for its review any material containing such results and intended for publication, or other disclosure, at least sixty
Publication Review. All publications (abstracts and manuscripts) resulting from the use of the SAMPLES must be forwarded to the PSC prior to submission to assess whether or not clinical data within the abstract or manuscript from clinical trial samples may be made publicly available prior to the completion of the clinical trial. All publications (abstracts and manuscripts) must be forwarded to the IVRN SC within one week of submission.
Publication Review. All Study Publications shall be submitted to the XXXXXX ALS Platform Trial Executive Committee for review by the XXXXXX ALS Platform Trial Executive Committee at least forty-five (45) days prior to the submission of the Study Publication. Xxxxxx Center shall advise the Site within forty-five (45) days of receiving any Study Publication if the Study Publication: (i) contains or discloses any potentially patentable inventions (“Patentable Material”), or (ii) contains any Xxxxxx Center or Company Confidential Information. Site will delete any Patentable Material or Confidential Information.
Publication Review. In the case of any paper, technical report or abstract, summary or synopsis thereof intended to be published or presented by Licensor, ("paper"), Licensor shall provide Licensee with an advance copy. If a patent application has already been filed with respect to all inventions described therein, Licensor shall send Licensee a final form copy thereof at least thirty (30) days prior to submission for publication nor any public disclosure thereof ("disclosure"). In all other cases, Licensor shall, at least forty five (45) days prior to disclosure, send Licensee a final form copy of each paper. In such cases, Licensee may require Licensor to delay making such proposed disclosure for a maximum of an additional forty five (45) days in order to protect the potential patentability of any invention described therein. (In the case of non-patentable, but confidential information contained in a paper, the parties shall negotiate an acceptable version for publication within ninety (90) days after notification). Licensor shall use his best efforts and cooperate with Licensee insuring that any improvement or invention in the Field identified by Licensee in such paper or report is filed by Licensor as a patent application.
Publication Review. For the purpose of restricting any disclosure of the other Party’s Confidential Information, the publishing Party or, in the case of joint Research Publications, the lead publishing Party (“Publishing Party”) agrees to send its proposed Research Publication for review and comment by the other Party (“Reviewing Party”). The Reviewing Party agrees to send its comments or suggested revisions to the proposed Research Publication to the Publishing Party within thirty (30) calendar days of receipt of the proposed Research Publication. It is agreed that if the Reviewing Party does not respond by the end of the thirty (30) calendar day review period, the Publishing Party may proceed with its proposed Research Publication; provided, however, if BWV is the Reviewing Party and has not responded by the end of the thirty (30) day review period, the Publishing Party agrees to provide written notification to BWV point of contact for publications below. Upon the Reviewing Party’s written request received within thirty (30) calendar days of its receipt of a proposed Research Publication, the Publishing Party agrees to delay its proposed Research Publication for up to thirty (30) additional calendar days to permit the preparation and filing of a patent application(s). The Publishing Party further agrees to delete from its proposed Research Publications any of the Reviewing Party’s Confidential Information unless the Reviewing Party agrees in writing to the inclusion of its Confidential Information in those Research Publications.
Publication Review. Xx. XxXxxxx agrees to submit to the Company's publications review committee any articles or writings Xx. XxXxxxx proposes to publish relating to the Confidential Material, whether or not the Confidential Material is identified as the Company's in the article, and to permit the committee a reasonable period of time consistent with its general practices to review such material and to require deletions of Confidential Material prior to publication. The review committee shall also be entitled delay publication of any article up to nine months for the convenience of the Company or longer, if necessary, to protect the Company's ability to file for patent protection.
